Banxia Xiexin Decoction (半夏泻心汤) Combined with Afatinib in Treatment of Advanced Gallbladder Cancer: Case Report and Literature Review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Banxia Xiexin Decoction (半夏泻心汤) Combined with Afatinib in Treatment of Advanced Gallbladder Cancer: Case Report and Literature Review

Published:2019-02-01 Issue:4 Volume:25 Page:303-306
ISSN:1672-0415
Container-title:Chinese Journal of Integrative Medicine
language:en
Short-container-title:Chin. J. Integr. Med.

Author:

Su Li,Wang Miao-miao,Xu Meng-ran,Wang Xiao,Xia Hong-zhen,Zhang Mei,Zheng Lei,Zhu Yao-dong,Wang Ming-qi,Li Ping

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Complementary and alternative medicine,General Medicine

Link

http://link.springer.com/article/10.1007/s11655-019-3152-1/fulltext.html

Reference21 articles.

1. Sharma A, Sharma KL, Gupta A, Yadav A, Kumar A. Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update. World J Gastroenterol 2017;23:3978–3998.

2. Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol 2014;6:99–109.

3. Kim BJ, Hyung J, Yoo C, Kim KP, Park SJ, Lee SS, et al. Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients. Cancer Chemother Pharmacol 2017;80:209–215.

4. Neal JW, Sledge GW. Decade in review-targeted therapy: successes, toxicities and challenges in solid tumours. Nat Rev Clin Oncol 2014;11:627–638.

5. Yang XB, Wu WY, Long SQ, Deng H, Pan ZQ, He WF, et al. Fuzheng Kang’ai Decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial. Trials 2015;16:146–152.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Observation on the therapeutic effect of chemotherapy combined with Banxia Xiexin decoction on duodenal cancer under CT enhanced scanning;INT J RADIAT RES;2023

2. Observation on the therapeutic effect of chemotherapy combined with Banxia Xiexin decoction on duodenal cancer under CT enhanced scanning;International Journal of Radiation Research;2023-10-01

3. Banxia Xiexin decoction: A review on phytochemical, pharmacological, clinical and pharmacokinetic investigations;Medicine;2023-09-01

4. Banxia xiexin decoction affects drug sensitivity in gastric cancer cells by regulating MGMT expression via IL‑6/JAK/STAT3‑mediated PD‑L1 activity;International Journal of Molecular Medicine;2021-07-05

5. Banxia Xiexin Decoction Inhibits the Expression of PD-L1 Through Multi-Target and Multi-Pathway Regulation of Major Oncogenes in Gastric Cancer;OncoTargets and Therapy;2021-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3